I thought this YT video reveals the incredible complexity of our human bodies and complexity of task that CIZ has embarked upon... https://www.youtube.com/watch?v=B2zreF2dnWk
About
Entrepreneurial and performance-driven Senior Executive with extensive background in direct sales, marketing, sales management, and business development, with a specialization in the healthcare market. Over 20 years’ experience selling to CEO’s, CFO’s, CMO’S, and Boards of Directors of health insurance companies and hospitals. Experienced at building and managing high-performing sales teams that beat competition, increase market share globally, and bring in new, multimillion dollar revenue customers. Significant success raising capital from venture capital firms, private equity firms, and accredited private investors. Proven ability to enter and expand new markets nationally where competitors have not been successful. Recognized as an effective team player and a creative problem solver with excellent communication and people skills.
??? Signature Achievements:
• Launched Home Care Dimensions, a home infusion, pharmacy, nursing, and home medical equipment company, for Princeton Medical’s Board of Directors. Built the company into the largest full-service provider in Texas.
• Worked with a $30 Billion Fortune 100 health insurance company to grow their network and Medicare business. Signed letter of agreement with large hospital system and recruited several physicians / groups to participate in the network.
• Partnered with a surgical company who had not sold a new contract in 27 months. Built and trained a new sales team that executed contracts worth an excess of $100 million in revenue at a 24% EBITA. Led the company to a successful exit.
• Worked with $100 Million regional service provider to revamp sales team and build new referral sources and revenue. Determined where changes in sales personnel needed to take place and executed plan. Assisted reps in growing territories resulting in hundreds of new referral sources
• Collaborated with early-stage technology company to expand business and compete in market. Developed strategic relationships with national partners and closed significant contracts with well-known healthcare organizations.
Following on from Neil's post... (from LinkedIn)
Senior Consultant Business DevelopmentSenior Consultant Business Development
Cizzle Biotechnology plc · ContractCizzle Biotechnology plc · Contract
Jan 2021 - Present · 1 yr 9 mosJan 2021 - Present · 1 yr 9 mos
London, England, United Kingdom
Senior ConsultantSenior Consultant
ProTom International · ContractProTom International · Contract
Jun 2021 - Present · 1 yr 4 mosJun 2021 - Present · 1 yr 4 mos
United StatesUnited States
A partnership between #sng synairgen and IQVIA? IQVIA are huge they did $11.3bn in revenue last year, listed on Nasdaq with MCAP of over $50bn
https://twitter.com/gggg2120/status/1478757750972854272?s=20
Could it be a sell? As you have suggested - we'll possibly get more information in the morning.
Doesn't make sense to me :-(
Interesting post from intelligentia8 over on advfn...
https://academic.oup.com/brain/advance-article/doi/10.1093/brain/awab337/6382473#.YWAjPE4REm4.twitter
May be of interest - https://www.reuters.com/business/healthcare-pharmaceuticals/astrazeneca-create-separate-division-vaccines-antibody-therapies-2021-11-09/
https://www.synairgen.com/contact-us/employment-opportunities/
Confused...
From Todays RNS...
"Gareth Walters, Ph.D., newly appointed Chief Regulatory Officer of Synairgen added : "I am thrilled to be joining Synairgen at such a pivotal moment for the Company. The anticipated conclusion of the Phase III trial in the coming months for SNG001 is a critical milestone for the Company in its goal of bringing interferon beta to hospitalised patients with COVID-19. I look forward to collaborating closely with the team and driving a global regulatory programme that helps deliver a therapy to patients that has the potential to reduce the burden on hospitals and healthcare systems."
Are we in Phase II awaiting results OR Phase III awaiting results?
Answers on a postcaed :-)
https://www.aerogen.com/ultra-for-intermittent-continuous-nebulisation/
...
Read More
Now results from 4,077 patients in the US show it can detect 67.6 per cent of 12 deadly cancers, including bowel, ovarian, lung and pancreatic.
AGM snippet... Shelflife -
In it's concentrated form - stable for over 5 years at minus 80 C (freezer ?)
In it's ready to use form - stable for 3 years at x (couldn't make it out) to 8 C (fridge)
The world is used to special handling procedures - so all very encouraging :-)